CA2192602A1 - Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaire - Google Patents
Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaireInfo
- Publication number
- CA2192602A1 CA2192602A1 CA 2192602 CA2192602A CA2192602A1 CA 2192602 A1 CA2192602 A1 CA 2192602A1 CA 2192602 CA2192602 CA 2192602 CA 2192602 A CA2192602 A CA 2192602A CA 2192602 A1 CA2192602 A1 CA 2192602A1
- Authority
- CA
- Canada
- Prior art keywords
- cell differentiation
- synergies
- apoptosis
- necrosis
- leukemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000006907 apoptotic process Effects 0.000 title abstract 2
- 208000032839 leukemia Diseases 0.000 title abstract 2
- 230000003211 malignant effect Effects 0.000 title abstract 2
- 230000017074 necrotic cell death Effects 0.000 title abstract 2
- 230000024245 cell differentiation Effects 0.000 title 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000006698 induction Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000003782 apoptosis assay Methods 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000005522 programmed cell death Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2192602 CA2192602C (fr) | 1996-12-11 | 1996-12-11 | Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaire |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2192602 CA2192602C (fr) | 1996-12-11 | 1996-12-11 | Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaire |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2192602A1 true CA2192602A1 (fr) | 1998-04-10 |
| CA2192602C CA2192602C (fr) | 1999-04-20 |
Family
ID=4159426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2192602 Expired - Fee Related CA2192602C (fr) | 1996-12-11 | 1996-12-11 | Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaire |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2192602C (fr) |
-
1996
- 1996-12-11 CA CA 2192602 patent/CA2192602C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2192602C (fr) | 1999-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ334034A (en) | Use of a melanoma differentiation associated gene (mda-7) for reversing a cancerous phenotype | |
| AU2938595A (en) | Mixing chamber arrangement | |
| DE58906377D1 (en) | Difluormethylverbindungen. | |
| CA2276455A1 (fr) | Phthalazinones | |
| AU4019295A (en) | Backpack or waistpack e.l. lighting arrangement | |
| AU4778997A (en) | Substituted 2,4-diamino-1,3,5-triazines as herbicides | |
| IL138015A0 (en) | Penetration-resistant ballistic article | |
| AU4289697A (en) | Tactical flashlight | |
| AU5901994A (en) | Tumor necrosis factor muteins | |
| AU5021799A (en) | Self-contained hyperbaric chamber | |
| BG103310A (en) | Benzonaphthyridins as bronchial therapeutical means | |
| AU1874195A (en) | Dual-view, immersible periscope | |
| AU4557897A (en) | Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides | |
| CY2483B1 (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation. | |
| EP0628612A3 (fr) | Compositions pigmentaires comportant des dispersants. | |
| AU4779097A (en) | Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides | |
| AU1044500A (en) | Imidazonaphthyridines | |
| AU1026999A (en) | Substituted 2,4-diamino-1,3,5-triazines | |
| AU4779197A (en) | Substituted 2,4-diamino-1,3,5-triazines as herbicides | |
| CY2538B1 (en) | Tetrahydropyrido compounds | |
| MXPA00001676A (es) | Reconector tipo tel (circuito disyuntor montado en un poste).. | |
| AU6500498A (en) | Substituted 2,4-diamino-1,3,5-triazines as herbicides | |
| CA2192602A1 (fr) | Induction de la differenciation cellulaire; apoptose et necrose de cellules malignes, comme dans la leucemie, a l'aide d'ozone et de synergies par des medicaments induisant la differenciation cellulaire | |
| ITTO920516A0 (it) | Procedimento ed apparecchiatura per la rpoduzione, in particolare domestica, di bevande. | |
| IL189502A0 (en) | Methods and compositions for inhibiting neoplastic cell growth |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |